GlassScriptPhysician profile
Michael James Glamore
NPI 1033522842
$8,018.92
in general payments reported to CMS, 2019-2025
45 companies · $2,163 in 2025
The $2,163 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $1,792 · 2021: $307 · 2022: $674 · 2023: $1,259 · 2024: $1,255 · 2025: $2,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,677.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,430.24 | 2023-2025 | Gemtesa, Orgovyx |
| Intuitive Surgical, INC. | $1,417.19 | 2020-2024 | |
| Olympus America INC. | $538.69 | 2019-2025 | Gyrus Acmi, Uropass, Uretero-Reno Videoscope |
| Janssen Biotech, INC. | $515.67 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Urovant Sciences INC | $419.30 | 2022 | |
| Boston Scientific Corporation | $334.73 | 2019-2025 | Ams 700, Rezum Generator, Axonics |
| Abbvie INC. | $261.10 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $245.07 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $222.91 | 2019-2023 | Myrbetriq |
| Biotissue Holdings INC. | $150.81 | 2024-2025 | |
| Astellas Pharma Global Development | $131.55 | 2025 | Xtandi |
| C. R. Bard, INC. & Subsidiaries | $130.51 | 2019-2025 | Bard X-Force Balloon Dilation Catheter |
| Merck Sharp & Dohme LLC | $104.14 | 2020-2024 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $96.96 | 2022-2025 | Prolaris |
| Pfizer INC. | $86.20 | 2019-2024 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $80.68 | 2021-2022 | |
| 180 Medical, INC. | $79.04 | 2021-2024 | Cure Ultra Catheter, Cure Catheter |
| Dornier Medtech America, INC | $64.43 | 2023 | Dornier Medtech |
| Angiodynamics, INC. | $50.00 | 2022-2023 | Nanoknife |
| Ambu INC. | $44.13 | 2020-2021 | |
| Teleflex LLC | $39.79 | 2025 | Barrigel |
| Karl Storz Endoscopy-America | $35.31 | 2019-2024 | |
| Amniox Medical, INC. | $31.32 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.78 | 2023 | |
| Hologic Sales and Service, LLC | $30.46 | 2025 | Coolseal Generator |
| Travere Therapeutics, INC. | $29.67 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $29.55 | 2025 | |
| Amgen INC. | $28.18 | 2020 | |
| Progenics Pharmaceuticals, INC. | $27.92 | 2025 | |
| Procept Biorobotics Corporation | $25.73 | 2025 | |
| Ethicon US, LLC | $25.28 | 2021 | |
| Ferring Pharmaceuticals INC. | $25.12 | 2025 | Adstiladrin |
| Dentsply Ih INC. | $24.90 | 2019 | |
| Profound Medical Corp. | $24.34 | 2022 | |
| Endo Pharmaceuticals INC. | $24.00 | 2023 | Xiaflex, Aveed, Edex |
| Dentsply Ih Ab | $22.80 | 2024 | Lofric |
| Valencia Technologies Corporation | $22.42 | 2025 | Ecoin Device Kit |
| Smith+Nephew, INC. | $20.53 | 2024 | Stravix |
| Agiliti Surgical, INC. | $19.57 | 2025 | Sonablate Hifu |
| Octapharma USA, INC. | $17.90 | 2025 | Fibryga |
| Laborie Medical Technologies Corp. | $17.30 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Allergan, INC. | $17.18 | 2020 | |
| Coloplast Corp | $15.62 | 2021 | |
| Axonics, INC. | $15.15 | 2021 | |
| Hollister Incorporated | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Glamore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.